SeraCare Life Sciences offers three new Accuvert seroconversion panels and one new Accuset performance panel.
The new Accuvert seroconversion panels are HCV seroconversion panel PHV924, providing undiluted plasma samples from a single male donor of genotype 2b, drawn over an 88-day period in 2008; HCV seroconversion panel PHV925, providing undiluted plasma samples from a single male donor of genotype 1a, drawn over a 27-day period in 2008; and HCV seroconversion panel PHV926, providing undiluted plasma samples from a single male donor of genotype 3a, drawn over a 14-day period in 2009.
SeraCare also released an anti-herpes mixed titer performance panel of naturally occurring, well-characterized plasma and serum specimens for use in developing, evaluating, and troubleshooting anti-HSV 1/2, anti-HSV 1, and anti-HSV 2 assays. The 21-member panel represents a range of reactivity to anti-HSV 1/2 IgG and IgM markers, from negative to strongly positive. Comprehensive test results for multiple industry assays are provided for comparative purposes.
SeraCare, 508-244-6400